🚨 NEW PUBLICATION 🚨
doi.org/10.3389/fimmu.2026.1…
CAR-T Exhaustion = A Major Barrier to Durable Remission 🧬⚡
CAR-T cells are powerful, but even engineered T cells can become exhausted.
Relapse after CAR-T is not always just antigen escape. Sometimes the engine burns out.
Key biology of CAR-T exhaustion:
• Tonic signaling before tumor contact
• CD28 vs 4-1BB = speed vs persistence
• PD-1/TIM-3/LAG-3/TIGIT = clues, not the whole story
• TOX/NR4A/BATF help lock in dysfunction
• The TME can starve, suppress, and reprogram CAR-T cells
What it looks like:
• poor expansion
• loss of persistence
• impaired tumor killing
• relapse after initial response
🧪 Next-gen strategies aim to keep CAR-T cells functional longer with smarter CARs, gene editing, armored CARs, rational combinations and more.
CAR-T failure is not one problem.
It’s a systems biology problem.
Check out our new
@FrontImmunol review for more:
doi.org/10.3389/fimmu.2026.1…
#CARTcells #Lymphoma #Immunotherapy #CellTherapy #HemeTwitter